Inventor · disambiguated record
Jason K. Myers
Also filed as: MYERS JASON · MYERS JASON K · MYERS JASON KENNETH
16 granted patents·4 pending applications·479 citations·filing 2001–2024
94Inventor score
Top patents by PatentIndex Score
20 records- 0195US6919359B2Azabicyclic-substituted-heteroaryl compounds for the treatment of diseasePFIZER·Filed 2002·Granted Jul 19, 2005·61 cites·23 claims
- 0295US6492385B2Quinuclidine-substituted heteroaryl moieties for treatment of diseaseUPJOHN CO·Filed 2001·Granted Dec 10, 2002·70 cites·97 claims
- 0393US8030304B2Thiazole pyrazolopyrimidines CRF1 receptor antagonistsLILLY CO ELI·Filed 2007·Granted Oct 4, 2011·35 cites·10 claims
- 0493US7001900B2Azabicyclic compounds for the treatment of diseasePFIZER·Filed 2003·Granted Feb 21, 2006·74 cites·5 claims
- 0592US6500840B2Quinuclidine-substituted heteroaryl moieties for treatment of diseaseUPJOHN CO·Filed 2001·Granted Dec 31, 2002·66 cites·52 claims
- 0691US6599916B2Quinuclidine-substituted heteroaryl moieties for treatment of diseaseUPJOHN CO·Filed 2001·Granted Jul 29, 2003·53 cites·52 claims
- 0789US6479510B2Quinuclidine-substituted aryl compounds for treatment of diseaseUPJOHN CO·Filed 2001·Granted Nov 12, 2002·41 cites·118 claims
- 0885US6562816B2Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of diseaseUPJOHN CO·Filed 2002·Granted May 13, 2003·26 cites·32 claims
- 0985US6486172B2Quinuclidine-substituted aryl compounds for treatment of diseaseUPJOHN CO·Filed 2001·Granted Nov 26, 2002·24 cites·60 claims
- 1083US6492386B2Quinuclidine-substituted aryl compounds for treatment of diseaseUPJOHN CO·Filed 2001·Granted Dec 10, 2002·19 cites·60 claims
- 1180US9637495B2CGRP receptor antagonistsLILLY CO ELI·Filed 2016·Granted May 2, 2017·2 cites·25 claims
- 1275US9708297B2CGRP receptor antagonistsLILLY CO ELI·Filed 2016·Granted Jul 18, 2017·2 cites·23 claims
- 1373US12421242B2Substituted tetrahydropyrrolo-pyridinone compounds and their use in treating medical conditionsKARUNA THERAPEUTICS INC·Filed 2024·Granted Sep 23, 2025·0 cites·50 claims
- 1472US6852716B2Substituted-aryl compounds for treatment of diseasePFIZER·Filed 2003·Granted Feb 8, 2005·6 cites·12 claims
- 1548US6869946B2Substituted azabicyclic moieties for the treatment of diseasePFIZER·Filed 2002·Granted Mar 22, 2005·0 cites·14 claims
- 1648US2005107425A1Treatment of attention defecit hyperactivity disorderPFIZER·Filed 2004·Application pending·0 cites
- 1746US2008132551A1Positive allosteric modulators of the nicotinic acetylcholine receptorPFIZER·Filed 2004·Application pending·0 cites
- 1843US2004157878A1Compounds as radioligands for the diagnosis of diseaseFiled 2003·Application pending·0 cites
- 1942US2003069296A1Substituted-aryl 7-aza[2.2.1]bicycloheptanes for the treatment of diseaseFiled 2002·Application pending·0 cites
- 2041US7868014B21-(hetero)aryl-3-amino-pyrrolidine derivatives for use as mGluR3 antagonistsLILLY CO ELI·Filed 2005·Granted Jan 11, 2011·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Jason K. Myers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →